Connect with us


Colchicine, a gout drug, shows preliminary promise for Covid-19 – STAT – STAT

Colchicine, a drug commonly used to treat gout, could reduce the risk people with mild Covid-19 will need to be hospitalized.



post featured image

A press release from a Canadian research group raised hopes that treating people recently diagnosed with Covid-19 with colchicine, a drug commonly used to treat gout, could reduce the risk they will need to be hospitalized.
But outside experts said the data provided were too limited to draw conclusions, leading to discussions of the risks of conducting science via press release, instead of in more detailed manuscripts in peer-reviewed journals. All hoped that colchicine, a cheap and globally available…

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
Merck says study shows COVID-19 drug causes quick reduction in virus – Reuters
Article feature image
CDC study finds mask mandates slow coronavirus spread; dining out can increase cases –
Article feature image
Morris Woman Believes ‘Post-COVID Psychosis’ Led to Husband’s Death – NBC Chicago